Skip to content

Clinical trials

Phase 3 Small Cell Lung Carcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Country / region: Italy Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20072
20111
20121
20162
20173
20182
20191
20202
20212
20222
20231
20243
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting9
Recruiting7
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Hoffmann-La Roche4
AstraZeneca3
AbbVie2
Bristol-Myers Squibb2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
PharmaMar2
Alaunos Therapeutics1
BioNTech SE1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma33
Lung Neoplasms6
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Small Cell1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.